Related Articles

News
STAT+: No more ‘playing God’: How the longevity field is trying to recast its work as serious science
January 30, 2023
San Francisco Biotechnology Network News
News
Comments Off on STAT+: No more ‘playing God’: How the longevity field is trying to recast its work as serious science
A small but growing community of CEOs and scientists are trying to recast the story of longevity so it’s digestible to the drug-making mainstream: less cover of Time magazine, more… […]

News
STAT+: Up and down the ladder: The latest comings and goings
January 6, 2023
San Francisco Biotechnology Network News
News
Comments Off on STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. […]

News
STAT+: Pharmalittle: Senate delays PBM-reform bill effective date; Gilead and HHS square off in court over HIV patents
May 2, 2023
San Francisco Biotechnology Network News
News, Syndication
Comments Off on STAT+: Pharmalittle: Senate delays PBM-reform bill effective date; Gilead and HHS square off in court over HIV patents
Pharmacy benefit managers may have gotten themselves a slight reprieve: Senators drafting reforms delayed their effective date by at least 10 months. […]